Kaken Pharmaceutical Co's market cap is currently ¥139.03B. The company's EPS TTM is ¥7.13; its P/E ratio is 11.66; and it has a dividend yield of 2.98%. Kaken Pharmaceutical Co is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in JPY
Kaken Pharmaceutical Co Earnings and Revenue History
